蛛网膜下腔出血管理与结局的18年趋势:单中心经验
该单中心观察性回顾研究纳入2002—2019年收治的1556例动脉瘤性蛛网膜下腔出血患者,评估管理方式与1年功能结局的演变。不良功能结局定义为改良Rankin量表评分4-6分。随时间推移,弹簧圈栓塞比例增加(p=0.004),迟发性脑缺血比例下降(p=0.03),1年死亡率下降(p<0.001),1年功能结局改善(p=0.002),不良功能结局相对风险降低38%(17-54%)。作者结论为2002—2019年间蛛网膜下腔出血患者1年功能结局改善、死亡率下降。
要点
- 2002—2019年单中心1556例动脉瘤性蛛网膜下腔出血患者中,329例(21%)为不良功能结局(改良Rankin量表评分4-6分)。
- 随时间推移弹簧圈栓塞比例增加(p=0.004),迟发性脑缺血比例下降(p=0.03)。
- 1年死亡率随时间下降(p<0.001),1年功能结局改善(p=0.002)。
- 不良功能结局相对风险降低38%(17-54%)。
适用人群与场景
- 2002—2019年连续收治于单中心高容量神经外科重症监护病房的所有动脉瘤性蛛网膜下腔出血患者。
诊断标准与关键阈值
- 不良功能结局定义为改良Rankin量表评分4-6分。
研究设计与关键结果
- 观察性回顾研究,纳入2002—2019年单中心神经外科重症监护病房连续收治的1556例动脉瘤性蛛网膜下腔出血患者,其中329例(21%)为不良功能结局。
- 随时间推移,弹簧圈栓塞手术比例增加(p=0.004),迟发性脑缺血比例下降(p=0.03)。
- 1年死亡率随时间下降(p<0.001),1年功能结局改善(p=0.002),不良功能结局相对风险降低38%(17-54%)。
证据类型、等级与局限
- 证据类型:观察性回顾研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Although subarachnoid hemorrhage-related mortality has decreased in recent years due to improvements in treatment, data on the evolution of 1-year functional outcomes after subarachnoid hemorrhage are lacking. The objective of this study was to evaluate the evolution of patient management and their functional outcomes 1 year after subarachnoid hemorrhage over time in a single high-volume neurosurgical intensive care unit.
METHODS: In this observational retrospective study, all consecutive patients with aneurysmal subarachnoid hemorrhage admitted to our neurosurgical intensive care unit between 2002 and 2019 were included. A poor functional outcome was defined as a modified Rankin Scale score of 4-6. Linear regressions were performed, and relative risk reductions of a poor functional outcome were calculated.
RESULTS: Between 2002 and 2019, 1556 patients were included, of whom 329 (21%) had a poor functional outcome. Over time, the percentage of coiling procedures (p = 0.004) increased, and the percentage of delayed cerebral ischemia (p = 0.03) decreased. One-year mortality decreased over time (p < 0.001), whereas 1-year functional outcome improved (p = 0.002), with a relative risk reduction of poor functional outcomes of 38% (17-54%).
CONCLUSIONS: The 1-year functional outcome of patients with subarachnoid hemorrhage improved between 2002 and 2019, and mortality decreased.
参考来源
- Renaudier M, Degos V, Pisanu G, et al. Eighteen-Year Trends in Subarachnoid Hemorrhage Management and Outcomes: A Single-Center Experience. Neurocrit Care. 2025. PMID: 40293698. doi:10.1007/s12028-025-02268-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。